There Is Clear Momentum For Coherus Biosciences Inc (NASDAQ: CHRS)
The Vanguard Group, Inc. has recently announced that it has increased stake in Coherus Biosciences Inc (NASDAQ:CHRS) by 4.89%. After grabbing 9.55 million shares, the institutional investor is now in possession of 0.44 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.58% having worth around $20.34 million. […]
